Metropolitan Police Investigate Lord Mandelson for Misconduct
The Metropolitan Police have initiated a criminal investigation into Lord Peter Mandelson for misconduct in public office, following revelations from the Jeffrey Epstein files that he allegedly leaked sensitive UK government information while serving as business secretary under Prime Minister Gordon Brown. The disclosures include details about a £20 billion asset sale and an imminent bailout package for the euro, which Mandelson reportedly communicated to Epstein. In response to the allegations, Mandelson has announced his retirement from the House of Lords, although he will retain his title unless legislation is passed to strip it.
Prince Andrew Discussed Afghanistan Investments with Epstein
Former Prince Andrew Mountbatten-Windsor engaged in discussions with Jeffrey Epstein regarding investment opportunities in Afghanistan while serving as a UK trade envoy, according to newly released U.S. Department of Justice documents. The correspondence, which included a 'confidential' briefing on reconstruction projects in Helmand province, took place on Christmas Eve 2010, shortly after Andrew had claimed to sever ties with Epstein. Prime Minister Sir Keir Starmer has called for Andrew to testify before the U.S. Congress in light of these revelations.
Report urges AI and video hearings to tackle court backlog
A report has recommended the increased use of artificial intelligence and video hearings to address the backlog of 80,000 criminal cases in the English courts system, which is facing significant challenges. A former senior judge has warned that the system is on the brink of collapse, highlighting the urgent need for reforms to manage the growing caseload.
UK finalizes £1 billion drug pricing deal with US
The UK government has finalized a £1 billion drug pricing deal with the US, confirmed by Science Minister Patrick Vallance, which will be funded by the Department of Health and Social Care over the next three years. This agreement, part of a 10-year arrangement, has raised concerns among opposition MPs about potential cuts to NHS services due to the 25% higher prices for new drugs. Campaigners warn that costs could escalate to £9 billion annually by 2035.
GSK to Lay Off 350 Employees in Strategic Shift
GSK announced plans to lay off up to 350 employees across its U.S. and U.K. workforces as part of a strategic reorientation of its investments. The layoffs will impact fewer than 70 individuals in the U.S. and fewer than 50 in the U.K., according to a report from Fierce Biotech. A company spokesperson stated that the restructuring aims to enhance scientific capabilities and productivity while focusing resources on key research and development sites over the next five years.
